SEARCH

SEARCH BY CITATION

References

  • 1
    Field K, Thorogood M, Silagy C, O’Neill C, Muir J. Strategies for reducing coronary risk factors in primary care: which is most effective? Br Med J 1995; 310: 1109 12.
  • 2
    Ebrahim S & Smith GD. Systematic review of randomised controlled trials of multiple risk factor interventions for preventing coronary heart disease. Br Med J 1997; 314: 1666 74.
  • 3
    Puska P, Tuomilehto J, Salonen JT et al. Changes in coronary risk factors during comprehensive five-year community programme to control cardiovascular diseases (North Karelia Project). Br Med J 1979; 2: 1173 8.
  • 4
    Luepker RV, Råstam L, Hannan PJ et al. Community education for cardiovascular disease prevention. Morbidity and mortality results from the Minnesota Heart Health Program. Am J Epidemiol 1996; 144: 351 62.
  • 5
    Multiple Risk Factor Intervention Trial Research Group (MRFIT). Multiple Risk Factor Intervention Trial. Risk factor changes and mortality results. JAMA 1982; 248: 1465 77.
  • 6
    Wilhelmsen L, Berglund G, Elmfeldt D et al. The multifactorial primary trial in Göteborg, Sweden. Eur Heart J 1986; 7: 279 88.
  • 7
    Ebrahim S & Davey Smith G. Health promotion for coronary heart disease: past, present and future. Eur Heart J 1998; 19: 1751 7.
  • 8
    Att förebygga sjukdom i hjärta och kärl genom befolkningsinriktade program-en systematisk litteraturöversikt. (To prevent cardiovascular disease with community-based programmes – a systematic review of the literature). Statens beredning för utvärdering av medicinsk metodik (The Swedish Council on Technology Assessment in Health Care), SBU-report nr.134. Stockholm, 1997.
  • 9
    Trell E. Community-based preventive medical department for individual risk factor assessment and intervention in an urban area. Prev Med 1983; 12: 397 402.
  • 10
    Adami HO. Sweden – a paradise for epidemiologists? Lancet 1996; 347: 588 9.
  • 11
    Eriksson K-F & Lindgärde F. No excess 12-year mortality in men with impaired glucose tolerance who participated in the Malmö Preventive Trial with diet and exercise. Diabetologia 1998; 41: 1010 16.
  • 12
    Petersson B, Krantz P, Kristensson H, Trell E, Sternby NH. Alcohol-related death: a major contributor to mortality in urban middle-aged men. Lancet 1982; ii: 1088 90.
  • 13
    Petersson B, Trell E, Kristensson H. Alcohol abstention and premature mortality in middle-aged men. Br Med J Clin Res Ed 1982; 285: 1457 9.
  • 14
    Petersson B, Trell E, Krantz P, Hood B. Major determinants of premature mortality in middle-aged urban males. Alcohol-related deaths and degree of participation in a preventive population program against alcohol and its complications. Am J Epidemiol 1984; 120: 265 72.
  • 15
    Kristensson H, Öhlin H, Hulthén-Nosslin MB, Trell E, Hood B. Identification and intervention of heavy drinkers in middle-aged men: Results and follow-up of 24–60 months of long-term study with randomized controls. Alcoholism Clin Exp Res 1983; 7: 203 9.
  • 16
    Petersson B, Kristenson H, Trell E, Hood B. Screening and intervention for alcohol-related disease in middle-aged men: the Malmö Preventive Programme. Ciba Found Symp 1985; 110: 143 63.
  • 17
    Berglund G, Eriksson K-F, Israelsson B et al. Cardiovascular risk groups and mortality in an urban Swedish male population: the Malmö Preventive Project. J Intern Med 1996; 239: 489 97.
  • 18
    Kjellström T, Lamme S, Mattiasson I et al. Design, findings and five-year follow-up of preventive medical lipid intervention clinic in Malmö. Scand J Prim Health Care 1985; 3: 177 81.
  • 19
    Eriksson KF & Lindgärde F. Impaired glucose tolerance in a middle-aged male urban population: a new approach for identifying high-risk cases. Diabetologia 1990; 33: 526 31.
  • 20
    Eriksson KF & Lindgärde F. Prevention of type 2 diabetes (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study. Diabetologia 1991; 34: 891 8.
  • 21
    Kristenson H & Trell E. Indicators of alcohol consumption. Comparison between a questionnaire (Mm-MAST), interviews and serum gamma-glutamyltransferase (GGT) in a health survey of middle-aged males. Br J Addict 1982; 77: 297 304.
  • 22
    Andersson I, Janzon L, Sigfusson BF. Mammographic breast cancer screening – a randomized trial in Malmö, Sweden. Maturitas 1985; 7: 21 9.
  • 23
    Andersson I, Aspegren K, Janzon L et al. Mammography screening and mortality from breast cancer: the Malmö mammography screening trial. Br Med J 1988; 297: 943 8.
  • 24
    Wilhelmsen L, Ljungberg S, Wedel H, Werkö L. A comparison between participants and non-participants in a primary preventive trial. J Chron Dis 1976; 29: 331 9.
  • 25
    Rosengren A, Wilhelmsen L, Berglund G, Elmfeldt D. Non-participants in a general population study of men, with special reference to social and alcoholic problems. Acta Med Scand 1987; 221: 243 51.
  • 26
    Multiple Risk Factor Intervention Trial Research Group. Mortality after 10, 1/2 years for hypertensive participants in the multiple risk factor intervention trial. Circulation 1990; 82: 1616 28.
  • 27
    Strandberg TE, Salomaa UV, Naukkarinen VA, Vanhanen HT, Sarna SJ, Miettinen TA. Cardiovascular morbidity and multifactorial primary intervention: Fifteen-year follow-up of the Helsinki Businessmen Study. Nutr Metab Cardiovasc Dis 1995; 5: 7 15.